Products

What will AGI do for Alifedrine?

This classification denotes a beta-adrenergic agonist with the molecular formula C18H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K2PM66M0VQ, chemically known as 1-propanone, 1-cyclohexyl-3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-, (r-(r*,s*))- but generally known as alifedrine, which bears US NIH Compound Identifier 51719. Alifedrine comes in base and hydrochloride forms. European Medicines Agency schedules Alifedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05325MIG. The term ALIFEDRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). ALIFEDRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alifedrine under HS 29225000 and SITC 51467. As of Q4 2014, ALIFEDRINE remains the US FDA Preferred Term for this commodity. Alifedrine bears US NLM identifiers UMLS ID C0051158 and NCI Concept Code C77931. SMILES: CC(C(C1=CC=CC=C1)O)NCCC(=O)C2CCCCC2.

How AGI delivers it

Four ways AGI delivers for Alifedrine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alifedrine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alifedrine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alifedrine connects

measured by

  • Assay Puritymodel
  • Melting Pointmodel
  • Particle Size Distributionmodel
  • Residual Solventmodel